Your browser doesn't support javascript.
loading
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace, Alex J; Conlon, Neil T; McDermott, Martina S J; Browne, Brigid C; O'Leary, Patrick; Holmes, Frankie A; Espina, Virginia; Liotta, Lance A; O'Shaughnessy, Joyce; Gallagher, Clair; O'Driscoll, Lorraine; Rani, Sweta; Madden, Stephen F; O'Brien, Neil A; Ginther, Charles; Slamon, Dennis; Walsh, Naomi; Gallagher, William M; Zagozdzon, Radoslaw; Watson, William R; O'Donovan, Norma; Crown, John.
Afiliación
  • Eustace AJ; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. alex.eustace@dcu.ie.
  • Conlon NT; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • McDermott MSJ; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Browne BC; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • O'Leary P; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Holmes FA; Texas Oncology-Memorial Hermann Memorial City, US Oncology Research, 925 Gessner Road #550, Houston, TX, 77024-2546, USA.
  • Espina V; George Mason University, Manassas, VA, USA.
  • Liotta LA; George Mason University, Manassas, VA, USA.
  • O'Shaughnessy J; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA.
  • Gallagher C; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • O'Driscoll L; School of Pharmacy & Pharmaceutical Sciences, and Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Rani S; School of Pharmacy & Pharmaceutical Sciences, and Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Madden SF; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • O'Brien NA; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Ginther C; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California, Los Angeles, USA.
  • Slamon D; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California, Los Angeles, USA.
  • Walsh N; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California, Los Angeles, USA.
  • Gallagher WM; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Zagozdzon R; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Watson WR; Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Nowogrodzka, 59, Warsaw, Poland.
  • O'Donovan N; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Crown J; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
BMC Cancer ; 18(1): 965, 2018 Oct 11.
Article en En | MEDLINE | ID: mdl-30305055
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Apoptosis / Resistencia a Antineoplásicos / Ligando Inductor de Apoptosis Relacionado con TNF / Lapatinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Apoptosis / Resistencia a Antineoplásicos / Ligando Inductor de Apoptosis Relacionado con TNF / Lapatinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Irlanda